China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals

🇨🇳 Reuters (CN) —
China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals

AI Summary

China's Hengrui and Bristol Myers Squibb have entered into collaboration and licensing deals to advance their respective biomedical research efforts. This partnership is expected to open new avenues for innovation in the healthcare sector.

Deals Health China Hengrui Bristol Myers Squibb collaboration

Read original source →